Correlation Between Eliem Therapeutics and Estrella Immunopharma
Can any of the company-specific risk be diversified away by investing in both Eliem Therapeutics and Estrella Immunopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eliem Therapeutics and Estrella Immunopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eliem Therapeutics and Estrella Immunopharma, you can compare the effects of market volatilities on Eliem Therapeutics and Estrella Immunopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eliem Therapeutics with a short position of Estrella Immunopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eliem Therapeutics and Estrella Immunopharma.
Diversification Opportunities for Eliem Therapeutics and Estrella Immunopharma
-0.5 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Eliem and Estrella is -0.5. Overlapping area represents the amount of risk that can be diversified away by holding Eliem Therapeutics and Estrella Immunopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Estrella Immunopharma and Eliem Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eliem Therapeutics are associated (or correlated) with Estrella Immunopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Estrella Immunopharma has no effect on the direction of Eliem Therapeutics i.e., Eliem Therapeutics and Estrella Immunopharma go up and down completely randomly.
Pair Corralation between Eliem Therapeutics and Estrella Immunopharma
Given the investment horizon of 90 days Eliem Therapeutics is expected to generate 21.61 times less return on investment than Estrella Immunopharma. But when comparing it to its historical volatility, Eliem Therapeutics is 4.99 times less risky than Estrella Immunopharma. It trades about 0.03 of its potential returns per unit of risk. Estrella Immunopharma is currently generating about 0.14 of returns per unit of risk over similar time horizon. If you would invest 5.29 in Estrella Immunopharma on September 2, 2024 and sell it today you would earn a total of 3.81 from holding Estrella Immunopharma or generate 72.02% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 47.3% |
| Values | Daily Returns |
Eliem Therapeutics vs. Estrella Immunopharma
Performance |
| Timeline |
| Eliem Therapeutics |
| Estrella Immunopharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Eliem Therapeutics and Estrella Immunopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Eliem Therapeutics and Estrella Immunopharma
The main advantage of trading using opposite Eliem Therapeutics and Estrella Immunopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eliem Therapeutics position performs unexpectedly, Estrella Immunopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Estrella Immunopharma will offset losses from the drop in Estrella Immunopharma's long position.| Eliem Therapeutics vs. Pmv Pharmaceuticals | Eliem Therapeutics vs. MediciNova | Eliem Therapeutics vs. Pharvaris BV | Eliem Therapeutics vs. PepGen |
| Estrella Immunopharma vs. Hf Foods Group | Estrella Immunopharma vs. Encore Capital Group | Estrella Immunopharma vs. SunOpta | Estrella Immunopharma vs. Tyson Foods |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Complementary Tools
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |